Nagendra Prasad Krishnamurthy (Nagendra Prasad K)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cross Sectional

Top Venues

Global advances in integrative medicine and health

This page only lists publications with an associated author ORCID identifier.

Publications

Vinu Vijayakumar, Srikanth N Jois, Sumanth Mallikarjuna Majgi, Nagendra Prasad Krishnamurthy, Roopa Nanjunda Swamy
Time to sense biofield (Prana) experiences between hands: A preliminary single blinded randomized placebo controlled trial. F1000Research 12 (2024)
Vinu Vijayakumar, Srikanth N Jois, Sumanth Mallikarjuna Majgi, Nagendra Prasad Krishnamurthy, Roopa Nanjunda Swamy
Time to sense biofield (Prana) experiences between hands: A preliminary single blinded randomized placebo controlled trial. F1000Research 12 (2024)
Vinu Vijayakumar, Srikanth N Jois, Sumanth Mallikarjuna Majgi, Nagendra Prasad Krishnamurthy, Roopa Nanjunda Swamy
Time to sense biofield (Prana) experiences between hands: A preliminary single blinded randomized placebo controlled trial. F1000Research 12 (2024)
Vinu Vijayakumar, Srikanth N Jois, Sumanth Mallikarjuna Majgi, Nagendra Prasad Krishnamurthy, Roopa Nanjunda Swamy
Time to sense biofield (Prana) experiences between hands: A preliminary single blinded randomized placebo controlled trial. F1000Research 12 (2024)
Vinu Vijayakumar, Srikanth N Jois, Sumanth Mallikarjuna Majgi, Nagendra Prasad Krishnamurthy, Roopa Nanjunda Swamy
Time to sense biofield (Prana) experiences between hands: A preliminary single blinded randomised controlled trial. F1000Research 12 (2023)
Manasa Belal, Vinu Vijayakumar, Nagendra Prasad Krishnamurthy, Srikanth N Jois
Perception of Subtle Energy " Prana ", and Its Effects During Biofield Practices: A Qualitative Meta-Synthesis. Global advances in integrative medicine and health 12 (2023)
Vinu Vijayakumar, Srikanth N Jois, Sumanth Mallikarjuna Majgi, Nagendra Prasad Krishnamurthy, Roopa Nanjunda Swamy
Time to sense biofield (Prana) experiences between hands: A preliminary single blinded randomised controlled trial. F1000Research 12 (2023)